Skip to content
You are not logged in |Login  

LEADER 00000cam a2200721Mi 4500 
001    ocn794770199 
003    OCoLC 
005    20210410013749.7 
006    m     o  d         
007    cr |n||||||||| 
008    120515s2012    caua    ob    001 0 eng d 
019    961518600|a962635498 
020    0804781915|q(electronic book) 
020    9780804781916|q(electronic book) 
020    |z9780804780544|q(alkaline paper) 
020    |z0804780544|q(alkaline paper) 
035    (OCoLC)794770199|z(OCoLC)961518600|z(OCoLC)962635498 
037    22573/ctvqrrv7h|bJSTOR 
040    NhCcYBP|beng|epn|cUBY|dE7B|dOCLCO|dYDXCP|dOCLCQ|dN$T|dOTZ
       |dOCLCQ|dOCLCF|dOCLCO|dOCLCQ|dAZK|dLOA|dAGLDB|dOCLCQ|dJBG
       |dOCLCQ|dPIFAG|dOCLCQ|dESU|dOCLCQ|dWRM|dNRAMU|dOCLCA|dINT
       |dWYU|dOCLCQ|dSTF|dOCLCQ|dJSTOR|dQGQ 
043    a-ii---|ad------ 
049    RIDW 
050  4 HD9672.I42|bS67 2012 
072  7 BUS|x070000|2bisacsh 
072  7 BUS|x068000|2bisacsh 
082 04 338.4/761510954|223 
090    HD9672.I42|bS67 2012 
100 1  Srinivas, Smita,|0https://id.loc.gov/authorities/names/
       nr2002029576|eauthor. 
245 10 Market menagerie :|bhealth and development in late 
       industrial states /|cSmita Srinivas. 
264  1 Stanford, California :|bStanford Economics and Finance, an
       imprint of Stanford University Press,|c2012. 
300    1 online resource 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
347    data file|2rda 
504    Includes bibliographical references and index. 
505 00 |gMachine generated contents note:|gpt. I|tMarket 
       Menagerie: Planning the Health of Late Industrial 
       Development --|tIntroduction --|tHealth and Development in
       Late Industrial States --|tBarbarians at the Gate: Late 
       Industrial Supply --|tData, Methods, and Structure --
       |tChapters Ahead --|tAppendix: Sample Questions --|g1.
       |tWell Beyond Market Failure --|tTime for Integration: 
       Evolution of States and Markets --|tTechnology's Insights 
       for Markets --|tExtant Systems and the Weakness of 
       Ideology for Reform --|tBeyond Minimalism --|tBringing an 
       Evolutionary Perspective to Development --|tFine Touch --
       |gpt. II|t1950 -- 2000: Indian Market Menagerie --|g2.
       |tFirst Market Environment: Trouble in the Making --
       |tPhase I, 1950 -- 1970s: Coveted Universalism, Controlled
       Markets --|tCrucible for Learning: The Public-Sector 
       Effort --|tNehruvian Efforts in the Manufacture of 
       Medicines --|tPublic-Sector Legacy Today --|g3.
       |t"Essential" Markets, Public Health, and Private Learning
       --|t1970s and 1980s --|tProcess Patents --|tPrice Controls
       --|tMonopolies, MNCs, and Accelerated Indian Learning --
       |tTrouble in the Making: The New Drug Policy and 
       Production --|tTaking Stock --|g4.|tDemand and Democracy -
       -|tInstitutional Unraveling of Industrial Planning --
       |tPlanning for the Nation's Heartland and Outposts --
       |tDemand and the Health of Health-Care Financing --
       |tIndustrial Slowdown and Fiscal Inertia --|tUniversalism 
       and Demand Identities: From Control to Dissipation --
       |tReemergence of Nonmarket Institutions --|tRagged Edges 
       of Consumption and Delivery --|g5.|tSecond Market 
       Environment: Learning by Proving in Global Regulatory 
       Harmonization --|tNational Universalism and Global 
       Nationalism: The State's Loosening Hold on the Domestic 
       Market --|tInstitutional Shifts to Global Nationalism --
       |tExpansionist Market Tiers --|tGrowing Innovation, but 
       Not Access? --|tLooking Ahead --|g6.|tDemand as Necessary 
       but Not Sufficient: Vaccine Procurement Markets --
       |tVaccines --|tHealth for Some: The Development Mandate --
       |tInternational Procurement Markets: Beyond Government 
       Failure --|tProcurement's Effect --|tFine-Tuning Demand 
       Policy Instruments --|tLearning by Proving: Health Policy 
       as Industrial Policy --|g7.|tThird Market Environment: 
       Uncertain State of New Technologies --|tBringing the State
       Back into the Process --|tProcess, Process: New 
       Technologies Ahoy! --|tAdvances Nevertheless --|tNew 
       Technology Maps and Blurred Market Signposts: 
       Organizational Vignettes --|tFinally, Niches and Local 
       Relevance --|tNew Interactions for Old Players --|gpt. III
       |tInstitutional Basis for Industry and Health --|g8.
       |tHealth Technologies in Comparative Global Perspective --
       |tInstituting Welfare Regimes: Building the Double 
       Movement --|tPharmaceutical's Historical Advance: Early 
       Capabilities, Early Welfare --|tPrivate Property Markets -
       -|tCollective Rights and Markets in Welfare Institutions -
       -|tVarieties of Health-Care States --|tLate Industrial 
       Suppliers: Marrying Late Capabilities with Later Welfare -
       -|tRevisiting the Institutional Triad --|tMoving Forward: 
       Transitioning Developmental States --|g9.|tMarkets and 
       Metropolis --|tDesign of (Re)distribution --|tNation and 
       City in Development --|tUniversalism in Federalism: 
       Between Capitalism and Commune --|tIndustrial Welfare and 
       the City in Context --|tCities, Antibiotics, and 
       Universalism --|tFrom Poor Law to Welfare Paternalism in 
       England and India --|tAhmedabad, circa 1915 --|tBody 
       Corporal and Politic: Utopias in Universalism --|tQuest 
       for Healthy Places --|tNations and Cities: An Evolving 
       Social Contract? --|tLimited Double Movement: 
       Contractualism and Bo(u)nds of Exchange --|tConclusion: 
       Soft Determinism in the Market Menagerie --|tInfusing 
       Evolution into Economic Plans --|tPlanning Process and 
       Outcomes --|tSoft Determinism in a New Pharmaceutical 
       World --|tIntervening in Variety --|tEvolution and 
       Orchestration of the Social Contract --|tMarket Variety 
       and Morality: Planning with Small and Large "P." 
520 8  Srinivas examines technological advance and market 
       regulation in the health industries of nations such as 
       India, Brazil, South Africa, Nigeria, and China. 
       Pharmaceutical and life science industries can reinforce 
       economic development and industry growth, but not 
       necessarily positive health outcomes. Yet well-crafted 
       industrial and health policies can strengthen each other 
       and reconcile economic and social goals. This book 
       advocates moving beyond traditional market failure to 
       bring together three uncommonly paired themes: the growth 
       of industrial capabilities, the politics of health access,
       and the geography of production and redistribution. 
588 0  Print version record. 
590    eBooks on EBSCOhost|bEBSCO eBook Subscription Academic 
       Collection - North America 
650  0 Pharmaceutical industry|0https://id.loc.gov/authorities/
       subjects/sh85039713|xGovernment policy|0https://id.loc.gov
       /authorities/subjects/sh99005269|zIndia.|0https://
       id.loc.gov/authorities/names/n80125948-781 
650  0 Pharmaceutical industry|xTechnological innovations|0https:
       //id.loc.gov/authorities/subjects/sh85039715|zIndia.
       |0https://id.loc.gov/authorities/names/n80125948-781 
650  0 Health services accessibility|0https://id.loc.gov/
       authorities/subjects/sh92006496|zIndia.|0https://
       id.loc.gov/authorities/names/n80125948-781 
650  0 Medical policy|zIndia.|0https://id.loc.gov/authorities/
       subjects/sh2010101146 
650  0 Pharmaceutical industry|0https://id.loc.gov/authorities/
       subjects/sh85039713|xGovernment policy|0https://id.loc.gov
       /authorities/subjects/sh99005269|zDeveloping countries.
       |0https://id.loc.gov/authorities/subjects/sh85037341-781 
650  0 Pharmaceutical industry|xTechnological innovations|0https:
       //id.loc.gov/authorities/subjects/sh85039715|zDeveloping 
       countries.|0https://id.loc.gov/authorities/subjects/
       sh85037341-781 
650  0 Health services accessibility|0https://id.loc.gov/
       authorities/subjects/sh92006496|zDeveloping countries.
       |0https://id.loc.gov/authorities/subjects/sh85037341-781 
650  0 Medical policy|zDeveloping countries.|0https://id.loc.gov/
       authorities/subjects/sh2010101206 
650  7 Pharmaceutical industry|xGovernment policy.|2fast|0https:/
       /id.worldcat.org/fast/1060149 
650  7 Pharmaceutical industry.|2fast|0https://id.worldcat.org/
       fast/1060129 
650  7 Pharmaceutical industry|xTechnological innovations.|2fast
       |0https://id.worldcat.org/fast/1060184 
650  7 Health services accessibility.|2fast|0https://
       id.worldcat.org/fast/953278 
650  7 Medical policy.|2fast|0https://id.worldcat.org/fast/
       1014505 
651  7 India.|2fast|0https://id.worldcat.org/fast/1210276 
651  7 Developing countries.|2fast|0https://id.worldcat.org/fast/
       1242969 
655  4 Electronic books. 
776 08 |iPrint version:|z9780804780544|z0804780544|w(DLC)  
       2011043735 
856 40 |uhttps://rider.idm.oclc.org/login?url=http://
       search.ebscohost.com/login.aspx?direct=true&scope=site&
       db=nlebk&AN=713441|zOnline ebook via EBSCO. Access 
       restricted to current Rider University students, faculty, 
       and staff. 
856 42 |3Instructions for reading/downloading the EBSCO version 
       of this ebook|uhttp://guides.rider.edu/ebooks/ebsco 
901    MARCIVE 20231220 
948    |d20210519|cEBSCO|tEBSCOebooksacademic NEW April 9 4115
       |lridw 
994    92|bRID